Erasca (ERAS) Current Leases (2020 - 2026)
Erasca posted quarterly Current Leases of $5.3 million for Q1 2026, up 9.6% year-on-year from $4.8 million in Q1 2025, and up 3.65% on a QoQ basis from $5.1 million in Q4 2025.
Erasca (ERAS) has 7 years of Current Leases data on file, last reported at $5.3 million in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 9.6% year-over-year to $5.3 million; the trailing twelve-month figure through Mar 2026 stood at $5.3 million (up 9.6% YoY), and the FY2025 full-year result was $5.1 million, up 9.68% from the prior year.
- Current Leases for Q1 2026 stood at $5.3 million, up from $5.1 million in the prior quarter.
- Across five years, Current Leases topped out at $5.3 million in Q1 2026 and bottomed at $14000.0 in Q1 2022.
- The 5-year median for Current Leases is $4.1 million (2024), against an average of $3.5 million.
- The widest annual swing landed in 2022, when Current Leases plunged 77.36%; it then soared 22171.43% in 2023.
- A 5-year view of Current Leases shows it stood at $1.3 million in 2022, then surged by 204.21% to $4.0 million in 2023, then gained by 16.35% to $4.6 million in 2024, then rose by 9.68% to $5.1 million in 2025, then gained by 3.65% to $5.3 million in 2026.
- The last three Current Leases figures came in at $5.3 million (Q1 2026), $5.1 million (Q4 2025), and $4.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Erasca | 4.21 Bn | 3.97 Bn | - | 5.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.25 Mn |
| Dec 31, 2025 | 5.07 Mn |
| Sep 30, 2025 | 4.89 Mn |
| Jun 30, 2025 | 4.71 Mn |
| Mar 31, 2025 | 4.79 Mn |
| Dec 31, 2024 | 4.62 Mn |
| Sep 30, 2024 | 4.45 Mn |
| Jun 30, 2024 | 4.29 Mn |
| Mar 31, 2024 | 4.13 Mn |
| Dec 31, 2023 | 3.97 Mn |
| Sep 30, 2023 | 3.82 Mn |
| Jun 30, 2023 | 3.67 Mn |
| Mar 31, 2023 | 3.12 Mn |
| Dec 31, 2022 | 1.31 Mn |
| Sep 30, 2022 | 1.03 Mn |
| Jun 30, 2022 | 201,000.00 |
| Mar 31, 2022 | 14,000.00 |
| Dec 31, 2021 | 285,000.00 |
| Sep 30, 2021 | 864,000.00 |
| Jun 30, 2021 | 888,000.00 |
| Dec 31, 2020 | 877,000.00 |